Sintx Technologies (SINT) Stock Price, News & Analysis

Company Overview

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Key Stats

• Today's Range: $3.36 to $3.87
• 50-Day Range: $2.04 to $6.34
• 52-Week Range: $2.01 to $105.80
• Volume: 160,060 shs
• Average Volume: 683,264 shs
• Market Capitalization: $4.73 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Sintx Technologies Stock Analysis - MarketRank™

Sintx Technologies scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sintx Technologies.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sintx Technologies is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sintx Technologies is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Sintx Technologies has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.15% of the float of Sintx Technologies has been sold short.

Short Interest Ratio / Days to Cover

Sintx Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sintx Technologies has recently increased by 115.14%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sintx Technologies does not currently pay a dividend.

Dividend Growth

Sintx Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

6.15% of the float of Sintx Technologies has been sold short.

Short Interest Ratio / Days to Cover

Sintx Technologies has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sintx Technologies has recently increased by 115.14%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.72

News Sentiment

Sintx Technologies has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sintx Technologies this week, compared to 1 article on an average week.

Search Interest

11 people have searched for SINT on MarketBeat in the last 30 days. This is an increase of 1,000% compared to the previous 30 days.

MarketBeat Follows

1 people have added Sintx Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sintx Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.01% of the stock of Sintx Technologies is held by insiders.

Percentage Held by Institutions

Only 18.38% of the stock of Sintx Technologies is held by institutions.

SINT Stock Analysis - Frequently Asked Questions

How have SINT shares performed this year?

Sintx Technologies' stock was trading at $76.28 at the beginning of the year. Since then, SINT stock has decreased by 95.4% and is now trading at $3.52.
View the best growth stocks for 2024 here.

How were Sintx Technologies' earnings last quarter?

Sintx Technologies, Inc. (NASDAQ:SINT) announced its earnings results on Tuesday, August, 13th. The company reported ($3.61) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($996.20) by $992.59. The company earned $0.86 million during the quarter. Sintx Technologies had a negative net margin of 358.79% and a negative trailing twelve-month return on equity of 140.68%.

When did Sintx Technologies' stock split?

Sintx Technologies's stock reverse split on Tuesday, May 28th 2024. The 1-200 reverse split was announced on Tuesday, May 28th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

How do I buy shares of Sintx Technologies?

Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Sintx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sintx Technologies investors own include Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), NightHawk Biosciences (NHWK), NIO (NIO), Citius Pharmaceuticals (CTXR), T2 Biosystems (TTOO) and Boxlight (BOXL).

Company Calendar

• Last Earnings: 8/13/2024
• Today: 12/20/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SINT
• CUSIP: N/A
• CIK: 1269026
• Web: www.sintx.com
• Phone: (855) 839-3500
• Fax: N/A
• Employees: 43
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($50.56)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,260,000.00
• Net Margins: -358.79%
• Pretax Margin: -358.79%
• Return on Equity: -140.68%
• Return on Assets: -78.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.04
• Quick Ratio: 2.82

Sales & Book Value

• Annual Sales: $1.64 million
• Price / Sales: 2.92
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $329.74 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 1,343,000
• Free Float: 1,343,000
• Market Cap: $4.78 million
• Optionable: Not Optionable
• Beta: 1.50